Prostate Cancer
A multi-institutional study of 1,111 men with 4K score, multiparametric magnetic resonance imaging, and prostate biopsy.
August 8, 2023
The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer.
August 8, 2023
A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer.
August 7, 2023
68Ga-PSMA PET/CT for Response Evaluation of 223Ra Treatment in Metastatic Prostate Cancer.
August 7, 2023
NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancer.
August 7, 2023
The role of nuclear medicine tracers for prostate cancer surgery: from preoperative to intraoperative setting.
August 4, 2023
Regional differences in stage distribution and rates of treatment for adrenocortical carcinoma across United States SEER registries.
August 4, 2023